Cancer Research Horizons
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Infinitopes
21 Jan 2026
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
52North
6 Dec 2024
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
Cancer Research Horizons
More venture news
- 12 Mar 2026
LoxaLoxa raises a £2.7m seed round for embedded product protection at checkout
SeedCommerce - 11 Mar 2026
Spotlight PathologySpotlight Pathology lands a £1.4m seed round led by UK Innovation and Science Seed Fund to help in the diagnosis of blood cancers with AI-powered tools
SeedHealth - 9 Mar 2026
AugurAugur raises a £11m seed round led by Plural to monitor critical infrastructure and public spaces as security threats rise
SeedProperty
